Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07355478 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Asia Myelodysplastic Syndrome (MDS) Registry

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Mar 26, 2026 to Aug 11, 2026 · Eligibility criteria expanded, about 6 words · Study sites revised (3) Show 3 more changesShow less
    • Start date changed from estimate of Mar 26, 2026 to Aug 11, 2026
    • Eligibility criteria expanded, about 6 words
    • Study sites revised (3)
  2. Start date: Jan 28, 2026 to Mar 26, 2026 Study sites: 2 to 3v2 Show 1 more changeShow less
    • Study sites: 2 to 3
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to provide a contemporary view and offer invaluable insights into the demographic profiles, clinical characteristics, treatments, and real-world outcomes of individuals with myelodysplastic syndromes (MDS) in Asia.
Trial Details
NCT Number NCT07355478
Lead Sponsor Bristol-Myers Squibb
Conditions Myelodysplastic Syndromes (MDS)
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov